5dkr: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Crystal Structure of Calcium-loaded S100B bound to SBi29== | ==Crystal Structure of Calcium-loaded S100B bound to SBi29== | ||
<StructureSection load='5dkr' size='340' side='right' caption='[[5dkr]], [[Resolution|resolution]] 1.74Å' scene=''> | <StructureSection load='5dkr' size='340' side='right' caption='[[5dkr]], [[Resolution|resolution]] 1.74Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[5dkr]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5DKR OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5DKR FirstGlance]. <br> | <table><tr><td colspan='2'>[[5dkr]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Bovin Bovin]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5DKR OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5DKR FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=5CZ:2-[4-(4-CARBAMIMIDOYLPHENOXY)PHENYL]-1H-INDOLE-6-CARBOXIMIDAMIDE'>5CZ</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=5CZ:2-[4-(4-CARBAMIMIDOYLPHENOXY)PHENYL]-1H-INDOLE-6-CARBOXIMIDAMIDE'>5CZ</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5dkn|5dkn]], [[5dkq|5dkq]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5dkn|5dkn]], [[5dkq|5dkq]]</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5dkr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5dkr OCA], [http://pdbe.org/5dkr PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5dkr RCSB], [http://www.ebi.ac.uk/pdbsum/5dkr PDBsum]</span></td></tr> | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">S100B ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9913 BOVIN])</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5dkr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5dkr OCA], [http://pdbe.org/5dkr PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5dkr RCSB], [http://www.ebi.ac.uk/pdbsum/5dkr PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5dkr ProSAT]</span></td></tr> | |||
</table> | </table> | ||
== Function == | == Function == | ||
| Line 22: | Line 24: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Bovin]] | |||
[[Category: Alasady, M J]] | [[Category: Alasady, M J]] | ||
[[Category: Ansari, M I]] | [[Category: Ansari, M I]] | ||
Revision as of 15:34, 6 November 2017
Crystal Structure of Calcium-loaded S100B bound to SBi29Crystal Structure of Calcium-loaded S100B bound to SBi29
Structural highlights
Function[S100B_BOVIN] Weakly binds calcium but binds zinc very tightly-distinct binding sites with different affinities exist for both ions on each monomer. Physiological concentrations of potassium ion antagonize the binding of both divalent cations, especially affecting high-affinity calcium-binding sites. Binds to and initiates the activation of STK38 by releasing autoinhibitory intramolecular interactions within the kinase. Interaction with AGER after myocardial infarction may play a role in myocyte apoptosis by activating ERK1/2 and p53/TP53 signaling. Could assist ATAD3A cytoplasmic processing, preventing aggregation and favoring mitochondrial localization (By similarity).[1] Publication Abstract from PubMedThe drug pentamidine inhibits calcium-dependent complex formation with p53 (CaS100B.p53) in malignant melanoma (MM) and restores p53 tumor suppressor activity in vivo. However, off-target effects associated with this drug were problematic in MM patients. Structure-activity relationship (SAR) studies were therefore completed here with 23 pentamidine analogues, and X-ray structures of CaS100B.inhibitor complexes revealed that the C-terminus of S100B adopts two different conformations, with location of Phe87 and Phe88 being the distinguishing feature and termed the "FF-gate". For symmetric pentamidine analogues (CaS100B.5a, CaS100B.6b) a channel between sites 1 and 2 on S100B was occluded by residue Phe88, but for an asymmetric pentamidine analogue (CaS100B.17), this same channel was open. The CaS100B.17 structure illustrates, for the first time, a pentamidine analog capable of binding the "open" form of the "FF-gate" and provides a means to block all three "hot spots" on CaS100B, which will impact next generation CaS100B.p53 inhibitor design. Small Molecule Inhibitors of Ca-S100B Reveal Two Protein Conformations.,Cavalier MC, Ansari MI, Pierce AD, Wilder PT, McKnight LE, Raman EP, Neau DB, Bezawada P, Alasady MJ, Charpentier TH, Varney KM, Toth EA, MacKerell AD Jr, Coop A, Weber DJ J Med Chem. 2016 Jan 13. PMID:26727270[2] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. References
|
| ||||||||||||||||||||